Weexaminedthesurvivinexpressionpatternbyimmunohistochemistryin43fi-broadenomasand153ductalcarcinomasofthebreast.Thesubcellularlocalization ofsurvivin andtheintensityofimmunoreactionwereassessed.We analyzedthe differencesofsurvivinexpressionbetweenfibroadenomasandcarcinomas.Wealso correlatedthesurvivinexpressionpatternincarcinomaswithotherclinicomorphologicalparameterssuchastheageofpatients,thegradeandsizeofprimarytumor aswellasthelymphnodemetastasis.Overall,survivinwasdetectedin107/153 carcinomas(69.9%)andin26/43fibroadenomas(60.5%).Statisticalanalysisconfirmedsignificantcorrelationsbetweentheassessedparametersinfibroadenomas andcarcinomas.Gradeofcarcinomaswassignificantlyrelatedtosurvivinexpressioninbothsubcellularlocalizationandtheintensityofimmunoreaction.Tumor grade3wasassociatedwithnuclearpositivityandcombinednuclearandcytoplas-mic localization. Carcinomas larger than 20 mm showed nuclear and combined localizationin81%ofcasesandhigherintensityofsurvivinimmunoreactionwas alsonotablyrelatedtolargercarcinomas.Statisticallysignificantdifferenceswere alsoobservedbetweensubcellularsurvivinlocalizationandintensityofimmunoreaction.Ourresultsuggestthatnuclearaccumulationofsurvivinisassociatedwith proliferativefenotypeandsurvivinwasshowntobeaworseprognosticmarkerin breastductalcarcinoma.
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Introduction
Breastcarcinomaisstilloneofthemostcommon malignant tumors in women. It is also one of the leadingcausesofcancerdeathinfemalepatients [1] . Thebalancebetweencellproliferationandapoptosis controlsnormalbreastdevelopmentaswellasmaintains cellular homeostasis of tissues. Furthermore, thereisastrongevidencethattumorgrowthisnot justtheresultofuncontrolledproliferation,butalso ofreducedapoptosis [2] .Tumorcellscandevelopresistancetoapoptosisbyexpressionofanti-apoptotic proteins(inhibitorsofapoptosisproteins-IAP).IAP proteinswerefirstdiscoveredinbaculoviruses,where theywereshowntobeinvolvedinsuppressinghost celldeathresponsetoaviralinfection [3, 4] .Human genomeencodeseightIAPfamilymembers [5] .Survivin,however,hasanumberofdistinctfeaturesnot sharedwithotherIAPs.Itistheshortestpolypeptide consistingof142aminoacidresidues.Theexpression of survivin is cell cycle-regulated and occurs in the G2/M phase. It is undetectable in most terminally differentiatednormalcells,butitisabundantinembryonicandfetaltissuesaswellasinamajorityofhuman malignancies including breast carcinomas [6] . Survivinisamultifunctionalproteinthatcontrolscell divisionandinhibitionofapoptosisaswellasenhancesangiogenesis [7] .Itisalsooneofthechromosome passenger proteins and plays an important role in mitosisandspindlecheckpoints [8] .Survivinshuttles between nucleus and the cytoplasm and hence, canbeassociatedwithdifferentsubcellularcompartments [1, 9] .Duetolargequantitativedifferencein thelevelofsurvivinexpressioninmalignanttumors on the one hand, and in corresponding normal tissueontheotherhand,survivinappearstorepresent a promising prognostic biomarker [10] . The prognosticvalueofsurvivinexpressionisamatterofdiscussion.Forbreastcancerpatients,itsprognosticrole has been reported either nonexistent [9, 11, 12] or associatedwithanimproved [13] oradverseoutcome [7, 14, 15] .
The aim of this work was to investigate survivin expressionin153casesofbreastductalcarcinomaby usingimmunohistochemistryandtostudytheassociationbetweenitssubcellularcompartmentalization and clinicomorphological parameters. Furthermore, we studied the relationship of survivin expression pattern between breast carcinomas and 43 cases of fibroadenoma. In all cases, both the subcellular localization of survivin(nucleus-N,cytoplasm-C,orboth-NC) andtheintensityofimmunoreaction(weak+,moderate++,andstrong+++)wereassessed.
Material and methods

Patients
To achieve good reproducibility, the above-mentionedparameterswereevaluatedsemiquantitatively by two experienced observers separately (MA, SD). Thewell-knownthreescalescoringsystemwasused toassesstheintensityofimmunoreactionforsurvivin [16, 17] .Theageofpatients,grade,sizeofthetumor andlymphnodemetastasisweredesignatedtorepresentclinicomorphologicalparameters.
Statistical analysis
Statistical analysis was performed with Microsoft Excel with XLSTAT software package. χ 2 test was used to demonstrate the differences of survivin expressioninfibroadenomaandcarcinomacases,andto evaluatethecorrelationbetweensurvivinexpression pattern and the clinicomorphological parameters of carcinomas.Moreover,Cochran-Armitagetrendtest Monte Carlo method was used to evaluate whether the intensity of survivin immunoreaction correlates withthesurvivinsubcellularlocalization.P-valueless than0.05wasconsideredtoindicateastatisticalsig-nificance.
Results
Evaluation of immunohistochemical staining
In the group of 43 cases of breast fibroadenoma ( Fig. 1 The results of all expression profiles are summarizedinTableI.
Statistical analysis results
Statistically, the chi-square test revealed significantdifferencesinthesubcellularlocalizationofsurvivinexpressioninbreastfibroadenomasandbreast carcinomas(p<0.001)(TableI).
Statistical analysis also confirmed significant differencesintheintensityofsurvivinimmunoreactivity betweenbreastfibroadenomasandbreastcarcinomas (p<0.001)(TableI).
Age,grade,sizeandlymphnodemetastasisofcarcinomaswereallanalyzedinrelationtosurvivinexpression-subcellularlocalizationandimmunoreactivityintensity(TableII).Caseswithabsentsurvivin inexpressionwereincludedinthestatisticalanalysis aswell. Thestatisticalanalysisdidnotrevealanykindof significantrelation betweentheageand subcellular localization of survivin and the intensity of immunoreactivity. However, the grade of carcinomas was substantially related to survivin expression in both subcellular localization and the intensity of immunoreactivity.Carcinomaswithgrade1weresurvivin negativein48%ofcases,grade2in33%andgrade 3onlyin14%ofcases.Onthecontrary,grade3was associatedmainlywithnuclearpositivity(in38%of cases) and combined nuclear and cytoplasmic localization of survivin (in 43% of cases). Similarly, the intensityofsurvivinimmunoreactivitywasassociated withthegradeofcarcinoma(TableII).
A statistically significant relationship was also confirmed between survivin expression and the size of carcinoma (Table II) . Specimens smaller than 11 mm demonstrated absent survivin expression in 50% of cases, while specimens larger than 20 mm onlyin15%ofcases.Carcinomaslargerthan20mm showednuclearandcombined(bothnuclearandcytoplasmic) expression of survivin in 81% of cases, whileasolelycytoplasmicexpressionofsurvivinwas detectedonlyin3%ofcasesandabsentsurvivinex-pressionin15%ofcases.Furthermore,ahigherintensityofimmunoreactivityofsurvivinwasstatisticallysignificantlyrelatedtolargercarcinomas.
The positivity of lymph node metastasis did not show any relevant correlation with the immunohistochemicalcharacteristicsofsurvivinexpression(TableII).
Survivin positive carcinoma samples were also evaluated with regard to the relation between subcellularlocalizationandintensityofimmunoreactivityofsurvivinexpression.Sampleswithsolelycytoplasmiclocalizationofsurvivindemonstratedaweak intensity of immunoreactivity in 77% of cases and mild/strongintensityonlyin23%ofcases.Carcinomas with nuclear and combined (both nuclear and cytoplasmic) localization of survivin showed a weak intensity of immunoreactivity in 44% of cases and mild/strongintensityin56%ofcases. χ 2 test and Cochran-Armitage trend test Monte Carlo method revealed significant relation between thesubcelluarlocalizationandintensity(TableIII).
Discussion
Ourpresentworksummarizestheexpressionand discusses the functions of the most important IAP family member, survivin, in breast lesions. We assessed the survivin expression in 43 fibroadenomas and 153 carcinomas. While, the evaluation of survivinexpressioninvarioustypesofcancershasbeen reportedinnumerousstudies [3, 18] ,verylittlehas been published about the relationship of survivin withbenignandmalignanttumorsofthebreast.
In our panel of 43 fibroadenomas, we detected survivin expression in 26 cases (60.5%), whereas in 17cases(39.5%)survivinexpressionwasabsent.Our resultsareconsistentwithourpreviousinvestigation [19] .Asolelycytoplasmiclocalizationwaspresentin 24cases(55.8%),whileacombinednuclearandcytoplasmicimmunoreactionwasdetectedintwocases (4.7%).Onlyasmallnumberofstudieswasfocused onsurvivinexpressioninbenignbreasttumors.Survivin expression was reported by Ranade et al. [20] in 17/32 fibroadenoma cases (53%). In their study, immunopositivitywasobservedmainlyincytoplasm. Incontrasttoourresults,theauthorsfoundasolely nuclearexpressioninonlyonecaseoffibroadenoma. Ontheotherhand,ourresultsarealmostconsistent withtheobservationofRyanet al. [21] ,whodetected67.7%survivinpositivityinfibroadenomas(21/31 cases). Survivin expression in fibroadenomas is likely to result from the proliferation and/or dysplastic transformation of luminal epithelial cells [20] . It is awell-knownfactthatsurvivinpromotescellproliferation and angiogenesis, and inhibits apoptosis. In theprocessofcellproliferation,survivincontributes to make the sister chromatid segregation and the stabilization of mitotic spindle components during late mitosis more accurate [22] . Moreover, survivin associates with the microtubules of mitotic spindle. Adisruptionofthisinteractioncauseslossofitsfunctionandactivationofcaspases3and7 [23] .
Inouruniformgroupof153breastductalcarci-nomas,werevealedthreepatternsofimmunohistochemical positivity (only nuclear, only cytoplasmic, andcombinednuclearandcytoplasmic)inmalignant cells. Survivin was expressed in 107 cases (69.9%). Nuclear and combined nuclear and cytoplasmic localizationofsurvivinwasfoundin94cases(61.5%), while cytoplasmic localization was detected in 13 cases(8.4%).Nassaret al. [24] describednuclearlocalizationin84% ofbreastcarcinomacases.Inline withourfindings,otherresearchgroupsalsodemon- [13] detectednuclear reaction only in 31% of carcinomas, cytoplasmic positivity in 13%, and combined nuclear and cytoplasmic staining in 16% of these cases. Al-Joudi et al. [18] foundnuclearsurvivinpositivityin16.5% of carcinomas, cytoplasmic positivity in 24.1% of cases,and27.5%ofthestudycasesshowedbothnu-clearandcytoplasmiclocalizationsimultaneously. The importance and prognostic role of different subcellular survivin expression in breast cancer remains controversial. Individual parts of research focusing on the evaluation of survivin expression in tumors lead to conflicting results. When analyzed retrospectively,cancerpatientswithsurvivinoverexpressionintumorcellsexhibitedshortenedsurvival, associationwithunfavorablemarkersofdiseaseprogression,acceleratedratesofrecurrenceandincreased resistance to therapy [25, 26] . The relationship between such an aggressive behavior and survivin has beendescribedinawidespectrumofmalignancies, e.g.incolorectalandgastriccarcinoma,inneuroblastoma as well as in prostatic carcinoma [2, 27, 28] . However, the association of survivin with prognosis inbreastcancerpatientshasalwaysbeenambiguous [14] . Previous studies reported survivin expression to be either prognostically irrelevant [12] , associatedwithpoorprognosis [11] ,orassociatedwithgood prognosisinbreastcancerpatients [13] .Takinginto considerationthekeypositionofsurvivinintheinhibitionofapoptosis,inthepromotionofcellproliferationandintheinductionofangiogenesis,thereisan importantargumentthatthesurvivinoverexpression may be an indicator of a worse prognosis [29, 30] . Surprisingly, many recent studies acknowledge the subcellular localization of survivin in respect to the prognosisofbreastcarcinoma.Forexample,Brennan et al. [31] and Oh et al. [32] concludedthat differentprognosticinformationisassociatedwithnuclear and cytoplasmic survivin localization. While nuclearexpressioncorrelatedwithanunfavorableoverall survival,cytoplasmicsurvivinexpressionwasassociatedwithanimprovedoverallsurvival.Ourprevious studies [33, 34] alsodemonstratedthatnuclearand combinednuclearandcytoplasmicsurvivinreaction isassociatedwithworseprognosticparameters.However,thisisnotacaseofsolelycytoplasmicpositivity. Basedontheseresult,itseemsthatdifferentsurvivin localizationintumorcellsisassociatedwithdistinct functions. Survivin in cytoplasm may be related to theapoptoticprocessandmaybeinvolvedintheinhibitionofcelldeath [6, 29, 35] andpromotingcarcinogenesis [36] .Survivininnucleusmayparticipate in the regulation of cell proliferation and may lead to a proliferative aggressive phenotype [6, 31, 37] . Theimportanceofnuclear-cytoplasmicshuttlingof survivinisstillunderdiscussion.StudiesofKnaueret al. [38] andKnaueret al. [39] showedthatsurvivin movementiscontrolledbyanactivenuclearexport signal,whichisverynecessaryforitsanti-apoptotic function. The inhibition of this nuclear export signalmaycausethecancercellstobecomeincreasingly susceptibletoapoptosisinducedbychemotherapyor radiotherapy [39] .
Accordingtoourresults,payingattentiontothe intensityofimmunoreactionseemstoberatherimportant. In the carcinoma group, the intensity of immunoreactivityvariesfromweaktostrong.Moderate to strong positivity of immunoreaction dominated among positive cases (36.6%). On the other hand,predominantlyweakintensitywasdetectedin fibroadenomas.Therefore,wesupposethatstronger intensity of immunoreaction can be associated with a higher accumulation of survivin in cancer cells. Sugaet al. [40] demonstratedthatthetranscription levelsofsurvivinweresignificantlyhigherinthetumortissuesamples,and,contrarily,significantlylowerinthenormaltissuesamples. Anidealdiagnosticbiomarkershouldbeabsentin normaltissueorbenigntumors.Onthecontrary,it shouldbeexpressedinmalignanttumorcells,includingeventheirearlyorsmalllesions [41] .Statistically, we confirmed significant differences (p < 0.05) between the assessed parameters of immunohistochemical staining (intensity of staining and subcellularlocalizationofsurvivin)betweenfibroadenomas andcarcinomas.Inourpreviousobservation [19] ,we came to very similar results. Our results, combined withtheliteraturereview,demonstratethatsurvivin could certainly extend the panel of plausible biomarkersforbreastcarcinoma [42, 43] .
In addition, we studied the relationship between survivinexpressionpatternandclinicomorphological parameterssuchastheageofpatients,gradeandsize oftumoraswellaslymphnodemetastases.Theabove mentionedparametersbelongtoagroupofvalidated patientmetricsandtumor-associatedcharacteristics.
Age is a well known risk factor for breast carcinoma [44] .Ratesofbreastcarcinomaareratherlow in women under 40, when they begin to increase andbecomehighestinwomenaroundtheageof70. Nearlyhalfofallcasesarediagnosedinwomenaged 60andhigher.Inourcohortofpatients,62/153cases areovertheageof60(40.5%).However,statistically, there is no significant relation between age and subcellular survivin compartmentalization and the intensityofimmunoreaction.
Histological grading is a widely used system, which helps to stratify breast cancer patients into favorableandunfavorableoutcomegroups.Numerous studies validated and confirmed the prognostic importance of the grading system [45, 46] . Many researchgroupshavedemonstratedthatgradingprovidesvaluableclinicalinformationinbreastcarcino-ma.Theassessmentofpathologicalgradingisasignificantdeterminantforbreastcancerprognosticand isalsoassociatedwithtumorbiology [45] .Schwartz et al. [47] studied 161708 cases of breast cancer and concluded that histological grading remains awell-acceptedprognosticmarkerdespitechangesin tumorsizeandinvolvementoflymphnodes.
Basically,malignanttumorsareusuallygradedas grade1,grade2andgrade3(well,moderatelyand poorlydifferentiated).Asageneralrule,well-differentiatedtumors(G1)morecloselyresembletheparent tissueandarelessaggressivethantheirpoorlydifferentiatedcounterparts(G3).Takingintoaccountthe subcellularlocalizationofsurvivin,wedemonstrated a positive correlation of nuclear and combined nuclearandcytoplasmiclocationswithmoreaggressive G3 tumors. Interestingly, above mentioned subcellular compartmentalizations were also significantly associated with a higher intensity of immunohistochemicalreaction.
Thesizeofprimarytumorisveryvaluabletraditionalprognostic parameter [48] . Acouple ofwellknownfactshavebeenestablishedovertheyearswith regardtosize,e.g.thelargersizeoftumor,theworse outcome;thelargerdiameterofthetumor,themore axillarylymphnodesareaffectedbymetastases [49] . Theanalysisof1038patientsbyLargillieret al. [50] indicatedthattumorsize(>20mmvs.≤20mm)is a significant and independent parameter associated withoverallsurvival.Thesizeoftumorwasalsodeterminedtobeafactorrelatedtoanaggressivemetastaticbreastcancer [51] .Inourrecentstudy,wehave found a nuclear and combined survivin expression in81%ofcarcinomaslargerthan20mm.Similarly, a higher intensity of immunohistochemical reaction significantlycorrelatedwithalargercarcinoma. Thestatusoflymphnodesrepresentsapowerful and reliable prognostic feature. Numerous studies have proven a strong correlation between the involvementofthelymphnodeandthesizeoftumor. A very well known study of Carter et al. [52] used thedataof24740breastcancercasestoanalyzethe survivalofpatients.Lymphnodestatusanddiameter oftumorwerebothindicatedasindependentprognostic factors. Moreover, these authors also demonstrated that while the lymph node involvement increased,thesurvivaldecreased,regardlessofthesize oftumor;and,onthecontrary,assizeoftumorincreased, the survival status decreased, regardless of thelymphnodeinvolvement.However,therelation between the size of tumor and the lymph nodes in breastcancerwasbeyondthescopeofourstudy.Instead,wewereinterestedintherelationbetweenthe lymphnodestatusandthesubcellularlocalizationof survivinand,asaresult,wedidnotconfirmanysignificantcorrelation. [53, 54] .
To summarize our observations, we have confirmed an increasing survivin expression starting from benign lesions to its overexpression in a majority of primary ductal carcinomas. Furthermore, nuclearandcombinednuclearandcytoplasmicpattern as well as higher intensity of immunoreactions bothdominatedincarcinomacases.Thesubcellular compartmentalizationofsurvivinandtheintensityof reaction between benign and malignant tumors revealedsignificantdifferences(p<0.001).Asalready mentioned above, our results suggest that survivin maybeconsideredasapotentialbiomarkerforductal breast carcinoma. In addition, our analysis revealed thatnuclearandcombinednuclearandcytoplasmic survivinlocalizationaswellasmoderateandstrong intensity of immunoreaction were associated with grade 3 tumors, and tumor size more than 20 mm indiameter.Withregardtoourpreviousresults [19, 55, 56] andrecentdata,wecanconcludethatdifferentsubcellularcompartmentalizationsofthemultifunctionalproteinsurvivinpossessdistinctfunctions, andthattheaccumulationofnuclearsurvivinisrelatedtoaproliferativefenotype.Therefore,weconsider survivintobeaworseprognosticparameterinbreast carcinoma.
